FDA Inspection 1086471 — Catalent Pharma Solutions LLC
The FDA completed an inspection of Catalent Pharma Solutions LLC on Feb 1, 2019 in Morrisville, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 1, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Morrisville, NC (United States)
Additional Details
Bioanalytical BA/BE